USPTO serial 74371165
VITAMEDICA
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- PORTER, KATHLEEN C.
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VITAMEDICA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
ASTA MEDICA AKTIENGESELLSCHAFT
D-6000 Frankfurt 1, DE
ASTA MEDICA AKTIENGESELLSCHAFT
D-6000 Frankfurt 1, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Joseph A. DeGrandi
JOSEPH A DEGRANDI1850 M ST NW STE 800WASHINGTON, DC 20036UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 003 | cosmetics; namely, perfume, body lotions, skin lotions and cremes, bath and toilet soaps, cream bath, shampoos, hair lotions, dentrifices, throat sprays and mouthwashes for non-medical use and breath fresheners | ABANDONED | — |
| 005 | pharmaceutical preparations; namely, anorectics for the treatment of anorexia, analgetics/antirheumatics for the treatment of pains, antiallergics for the treatment of allergic diseases, antidotes for the treatment of toxicity and poisoning, antiemetics/antivertiginousics for the treatment of hyperemesis, vomiting, motion sickness, antihypertonics (antihypertensives) for the treatment of hypertension, antitussives/expectorants for treatment of all kind of coughs and mucous diseases, balneotherapeutics for the treatment of dermatopathy, dermatitis, betablockers used in the treatment of cardiac and cardiovascular diseases, calcium antagonists used in the treatment of cardiac and cardiovascular diseases, ace-inhibitors used in the treatment of cardiac and cardiovascular diseases, broncholytics/antiasthmatics used in the treatment of diseases of the respiratory tract, dermatics used in the treatment of all kinds of dermatic diseases, diagnostics reagents for clinical or medical laboratory use, diuretics for treatment of diuresis and hypertension, cardioactive agents used for the treatment of cardiac and cardiovascular diseases, coronary agents (vasodilators) for use in the treatment of coronary heart diseases, hepatica agents for use in the treatment of hepatic diseases, gastrointestinal agents for use in the treatment of gastrointestinal diseases, migraine agents for use in the treatment of migraine and headaches, mouth and throat therapeutics, muscle relaxants, ophthalmics for use in the treatment of ophthalmic diseases, preparations for the treatment of Parkinson's disease and against extrapyramidal disorders, psychotropic drugs for the treatment of psychotropic and psychotic diseases, rhinologics for use in the treatment of diseases of the respiratory tract, thyroid therapeutics, sera for clinical or medical laboratory use, immunoglobins for clinical or medical laboratory use, vaccines for use in the prevention of viral influenza for human use, sexual hormones and their inhibitors, cytostatic agents for use in the treatment of cancer, oncosis and carcinolysis, vitamin and mineral supplementals, and phytotherapeutics for use in the treatment of all kinds of inflammatory diseases as well as dermatic diseases | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by ASTA MEDICA AKTIENGESELLSCHAFT
- Other trademarks owned by ASTA MEDICA AKTIENGESELLSCHAFT
- Other trademarks in Class 003
- Other trademarks in Class 005
- Similar marks named VITAMEDICA
- Prosecution event ABN6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 29, 1996 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 19, 1996 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Jun 19, 1996 | EXT4 | SOU EXTENSION 4 FILED | — |
| Mar 5, 1996 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Dec 18, 1995 | EXT3 | SOU EXTENSION 3 FILED | — |
| Aug 9, 1995 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Jun 26, 1995 | EXT2 | SOU EXTENSION 2 FILED | — |
| Feb 7, 1995 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Dec 1, 1994 | EXT1 | SOU EXTENSION 1 FILED | — |
| Jun 28, 1994 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Apr 5, 1994 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Mar 4, 1994 | NPUB | NOTICE OF PUBLICATION | — |
| Jan 21, 1994 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 20, 1993 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 1993 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 15, 1993 | DOCK | ASSIGNED TO EXAMINER | — |